Compared with normal controls, ATG16L2, BAK1, RAB24, RGS19, ULK2, and WDFY3 were upregulated, whereas CAPN10, RPS6KB1, and CASP1 were downregulated in AD patients. Here, WDFY3 is linked to Alzheimer disease.